Sstr2 expression strongly correlates with luminal A markers (estrogen and progesterone receptor), and is typically not found in the other breast cancer subtypes (Dalm et al. 2015; Frati et al. 2014; Reubi & Torhorst 1989). Here, SSTR2 is linked to breast carcinoma.